The two organizations join forces to develop pioneering AI-based solutions for efficient chemical synthesis planning that accelerates the development of new drugs.
CAS, a division...
Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team. Moran will be the CRO's new VP...
Octave Bioscience, announced the closing of a $30M extension to its Series B funding round. The round included participation from new strategic investors: Novartis (dRx...
GrayMatter announces its largest strategic merger to date with the addition of Automation & Control Concepts, a leading St. Louis-based industrial control systems integrator.
"We're excited...
The US-based pharmaceutical and baby products company said that the proposed settlement, which still needs the approval of a bankruptcy court, "will equitably and...
